While brand-name weight loss drugs are in short supply, a market for alternatives thrives
High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...
Weight-loss drug developer BioAge raises $198 mln in U.S. IPO
BioAge Labs has raised $198 million after pricing its upsized U.S. initial public offering at the midpoint of the range at $18 per share, the weight-loss drug developer said on Wednesday.
Authorities seize nearly $270,000 worth of fake weight loss drugs in Cincinnati
There is no guarantee products purchased from unapproved sources online don't contain dangerous ingredients, per the agency.
Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments
To fight off compounding pharmacies, Eli Lilly wants access to medical records of patients who used copycat products.
shorenewsnetwork14h
New Law Seeks to Ban Weight Loss Drugs for Teens in New Jersey, While Allowing Gender Transitioning Treatments
New Jersey is a state with a gender healthcare sanctuary state. An executive order introduced in 2023 by Governor Phil Murphy ...
'Stop ripping us off': Ozempic producer CEO in hot seat in congressional hearing
Senators grilled Novo Nordisk CEO Lars Jørgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight ...